BioCentury | Oct 6, 2017
Financial News

Roivant to invest $116.4M in Arbutus

...the investment's close. Roivant's pipeline includes neurology, dermatology and endocrinology programs. In 2015, Arbutus predecessor Tekmira Pharmaceuticals Corp....
BioCentury | Oct 2, 2017
Financial News

Roivant to invest $116.4M in Arbutus

...the investment's close. Roivant's pipeline includes neurology, dermatology and endocrinology programs. In 2015, Arbutus predecessor Tekmira Pharmaceuticals Corp....
BioCentury | Oct 31, 2016
Company News

NeuroVive, Arbutus Biopharma deal

...OnCore Biopharma Inc. exclusive, worldwide rights to NVP018 to treat HBV infection. OnCore merged with Tekmira Pharmaceuticals Corp....
BioCentury | Oct 21, 2016
Company News

Arbutus returns cyclophilin inhibitor to NeuroVive

...HBV. OnCore, which was formed by a group of former Pharmasset Inc. executives, merged with Tekmira Pharmaceuticals Corp....
BioCentury | Jul 21, 2015
Company News

Tekmira changing name to Arbutus with HBV focus

...of TKM-Ebola to treat Ebola. The company will trade on NASDAQ under the ticker ABUS. Tekmira...
...house preclinical RNAi candidates, the company's LNP delivery technology platform, related IP and strategic partnerships. Tekmira...
...TKM-Ebola, and the non-HBV unit will evaluate strategic options for the candidate. Earlier this year, Tekmira...
BioCentury | Jun 22, 2015
Clinical News

TKM-Ebola-Guinea: Phase II data

...trial was sponsored by the University of Oxford and was slated to enroll 100 patients. Tekmira...
...and Zaire Ebola polymerase complex protein ( VP35 ) formulated with Tekmira’s LNP technology. Tekmira Pharmaceuticals Corp....
...Description: Short interfering RNAs (siRNAs) targeting the Guinea (Makona) strain of Ebola virus formulated with Tekmira’s...
BioCentury | Jun 22, 2015
Analyst Picks & Changes

Analyst picks & changes

...of C-type natriuretic peptide (CNP; NPPC), to treat achondroplasia, which is a form of dwarfism. Tekmira Pharmaceuticals Corp....
...targeting polo-like kinase 1 (PLK1; STPK13) is in Phase II for cancer. Kolbert noted that Tekmira...
...include any value for them in his model. After Kolbert issued his report last week, Tekmira...
BioCentury | Jun 20, 2015
Clinical News

Tekmira falls on Ebola data

...Ebola virus infection. As a result, the company said enrollment in the study was closed. Tekmira's...
...with Tekmira's lipid nanoparticle (LNP) technology. The study's primary endpoint was mortality at 14 days. Tekmira...
...determine next steps for TKM-Ebola-Guinea after it receives full data from the trial next quarter. Tekmira...
BioCentury | Jun 18, 2015
Distillery Therapeutics

Therapeutics: Enolase 1 α (ENO1)

...a liposomal formulation of doxorubicin, to treat Kaposi's sarcoma, multiple myeloma (MM) and ovarian cancer. Tekmira Pharmaceuticals Corp....
BioCentury | Apr 27, 2015
Clinical News

Patisiran: Extension study additional data

...expansion of a 2012 RNAi deal (see BioCentury, Oct. 29, 2012 & Jan. 20, 2014). Tekmira Pharmaceuticals Corp....
Items per page:
1 - 10 of 242
BioCentury | Oct 6, 2017
Financial News

Roivant to invest $116.4M in Arbutus

...the investment's close. Roivant's pipeline includes neurology, dermatology and endocrinology programs. In 2015, Arbutus predecessor Tekmira Pharmaceuticals Corp....
BioCentury | Oct 2, 2017
Financial News

Roivant to invest $116.4M in Arbutus

...the investment's close. Roivant's pipeline includes neurology, dermatology and endocrinology programs. In 2015, Arbutus predecessor Tekmira Pharmaceuticals Corp....
BioCentury | Oct 31, 2016
Company News

NeuroVive, Arbutus Biopharma deal

...OnCore Biopharma Inc. exclusive, worldwide rights to NVP018 to treat HBV infection. OnCore merged with Tekmira Pharmaceuticals Corp....
BioCentury | Oct 21, 2016
Company News

Arbutus returns cyclophilin inhibitor to NeuroVive

...HBV. OnCore, which was formed by a group of former Pharmasset Inc. executives, merged with Tekmira Pharmaceuticals Corp....
BioCentury | Jul 21, 2015
Company News

Tekmira changing name to Arbutus with HBV focus

...of TKM-Ebola to treat Ebola. The company will trade on NASDAQ under the ticker ABUS. Tekmira...
...house preclinical RNAi candidates, the company's LNP delivery technology platform, related IP and strategic partnerships. Tekmira...
...TKM-Ebola, and the non-HBV unit will evaluate strategic options for the candidate. Earlier this year, Tekmira...
BioCentury | Jun 22, 2015
Clinical News

TKM-Ebola-Guinea: Phase II data

...trial was sponsored by the University of Oxford and was slated to enroll 100 patients. Tekmira...
...and Zaire Ebola polymerase complex protein ( VP35 ) formulated with Tekmira’s LNP technology. Tekmira Pharmaceuticals Corp....
...Description: Short interfering RNAs (siRNAs) targeting the Guinea (Makona) strain of Ebola virus formulated with Tekmira’s...
BioCentury | Jun 22, 2015
Analyst Picks & Changes

Analyst picks & changes

...of C-type natriuretic peptide (CNP; NPPC), to treat achondroplasia, which is a form of dwarfism. Tekmira Pharmaceuticals Corp....
...targeting polo-like kinase 1 (PLK1; STPK13) is in Phase II for cancer. Kolbert noted that Tekmira...
...include any value for them in his model. After Kolbert issued his report last week, Tekmira...
BioCentury | Jun 20, 2015
Clinical News

Tekmira falls on Ebola data

...Ebola virus infection. As a result, the company said enrollment in the study was closed. Tekmira's...
...with Tekmira's lipid nanoparticle (LNP) technology. The study's primary endpoint was mortality at 14 days. Tekmira...
...determine next steps for TKM-Ebola-Guinea after it receives full data from the trial next quarter. Tekmira...
BioCentury | Jun 18, 2015
Distillery Therapeutics

Therapeutics: Enolase 1 α (ENO1)

...a liposomal formulation of doxorubicin, to treat Kaposi's sarcoma, multiple myeloma (MM) and ovarian cancer. Tekmira Pharmaceuticals Corp....
BioCentury | Apr 27, 2015
Clinical News

Patisiran: Extension study additional data

...expansion of a 2012 RNAi deal (see BioCentury, Oct. 29, 2012 & Jan. 20, 2014). Tekmira Pharmaceuticals Corp....
Items per page:
1 - 10 of 242